A coalition of 128 Republican lawmakers has formally requested that the Department of Health and Human Services (HHS) Inspector General initiate a comprehensive review of Planned Parenthood’s use of federal funds. Led by Rep. Chris Smith, R-N.J., and Sen. James Lankford, R-Okla., the bicameral effort asks the Office of Inspector General (OIG) to determine if the organization and its affiliates have complied with federal laws and funding requirements. The request casts a wide net, seeking scrutiny of funding flowing through HHS programs, grants, contracts, and sub-awards to identify evidence of fraud, waste, abuse, or misrepresentation.
The lawmakers’ letter emphasizes the need for accountability regarding significant taxpayer resources. "Given the significant taxpayer resources that flow through federal health and human services programs, it is critical that recipient organizations operate with transparency, integrity, and full compliance with federal standards," the legislators wrote. They are asking the OIG to coordinate with the Centers for Medicare & Medicaid Services (CMS) and the Office of Management and Budget (OMB) for this "comprehensive review." If misconduct is uncovered, the lawmakers suggest consequences ranging from administrative remedies and suspension to exclusion from federal healthcare programs or referrals to other authorities.
What the Left Is Saying
Planned Parenthood Federation of America did not immediately respond to requests for comment regarding the specific letter from the 128 lawmakers. The organization has historically maintained that its federal funding is subject to rigorous audits and that it complies with all applicable laws, including the prohibition on using federal funds for elective abortions. Progressive advocates typically argue that such legislative pushes are politically motivated efforts to defund the organization rather than genuine attempts to address financial irregularities. They point out that the organization provides essential health services, including cancer screenings and STI tests, to millions of Americans, many of whom rely on sliding-scale fees supported by these federal dollars.
What the Right Is Saying
Rep. Chris Smith, co-chairman of the Congressional Pro-Life Caucus, stated that the scrutiny is "long overdue." He cited allegations involving federal funding, reporting requirements, sexual exploitation, and fetal tissue. "It is long overdue for a comprehensive investigation and review, and I urge the HHS OIG to look closely to determine whether it has violated federal standards for federal funding recipients," Smith said. Sen. James Lankford, R-Okla., argued that the allegations deserve a thorough review. "The HHS Inspector General should follow the facts, determine whether federal laws and funding requirements have been violated, and hold accountable anyone who has misused taxpayer dollars," Lankford stated. The lawmakers also pointed to reports alleging failures to comply with mandatory reporting requirements involving suspected child abuse or neglect, though they noted these allegations have not yet been established as findings by the HHS-OIG.
What the Numbers Show
The request for a probe coincides with a separate review by the Small Business Administration (SBA) concerning more than $88 million in COVID-era Paycheck Protection Program (PPP) loans received by 38 Planned Parenthood affiliates. While the lawmakers characterized the SBA action as an investigation into whether these affiliates "illegally received" the funds, the SBA has described its action as a review of whether the affiliates were eligible for the loans. This distinction is critical: the SBA review is not a finding that the affiliates violated the law. The OIG request extends beyond these pandemic loans to examine broader HHS funding streams. As of the latest reports, the HHS-OIG stated it had not yet received the letter from the lawmakers but would "review it for appropriate action once received."
The Bottom Line
The move signals a continued legislative focus on the financial oversight of major nonprofit healthcare providers, particularly those receiving substantial federal appropriations. If the OIG proceeds with an investigation, it could lead to administrative actions or referrals to the Department of Justice, potentially impacting Planned Parenthood’s operational capacity and funding stability. The situation remains in the preliminary stages, as the OIG has not yet acknowledged receipt of the formal request. Readers should note that while the lawmakers allege potential violations, no official findings of fraud or non-compliance have been issued by federal auditors at this time. The outcome of the OIG’s decision to act on the letter will determine the next phase of this regulatory scrutiny.